Drug:
Reaction: INFLUENZA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26546620 |
US |
39 | 2 |
Influenza, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FAMOTIDINE, EPINEPHRINE, ALBUTEROL SULFATE, ALBUTEROL, PROPRANOLOL HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FERROUS SULFATE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 102 | 26535875 |
AU |
57 | 1 |
Cytomegalovirus viraemia, Cytomegalovirus infection reactivation, Vocal cord paralysis, Influenza, Pneumonia bacterial, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, PREDNISONE, ISATUXIMAB, POMALIDOMIDE, FENTANYL, PROPOFOL, |
||||
| 103 | 26535891 |
CO |
3 | 2 |
Chills, Adenovirus infection, Influenza, Pyrexia, Oxygen saturation decreased, |
||||
NUSINERSEN, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST, |
||||
| 104 | 26536032 |
US |
43 | 2 |
Influenza, |
||||
TREPROSTINIL, TREPROSTINIL, DULOXETINE HYDROCHLORIDE, DULOXETINE, FAMOTIDINE, SUMATRIPTAN SUCCINATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SIMVASTATIN, RIVAROXABAN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TADALAFIL, KETAMINE HYDROCHLORIDE, ALBUTEROL SULFATE, GABAPENTIN, CLONIDINE, KETOPROFEN, OXYGEN, 0XYGEN, COLCHICINE, SPIRONOLACTONE, BUMETANIDE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMITRIPTYLINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ONDANSETRON HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 105 | 26536360 |
US |
54 | 2 |
Influenza, |
||||
TIRZEPATIDE, |
||||
| 106 | 26536620 |
CA |
46 | 1 |
Hypoglycaemia, Chills, Diarrhoea, Diverticulitis, Dysgeusia, Fatigue, Headache, Influenza, Nausea, Vomiting, Weight decreased, Injection site erythema, Injection site pruritus, Injection site rash, Therapy partial responder, Intentional dose omission, Inappropriate schedule of product administration, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROXYCHLOROQUINE SULFATE, CLONAZEPAM, DICLOFENAC, DICLOFENAC SODIUM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, SEMAGLUTIDE, SEMAGLUTIDE, ERGOCALCIFEROL, |
||||
| 107 | 26536801 |
US |
2 | |
Influenza, Pneumonia, Atrial fibrillation, |
||||
LEVOTHYROXINE SODIUM, BIOTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ACARBOSE, METOPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, ERGOCALCIFEROL, VITAMIN C, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 108 | 26536837 |
CA |
2 | |
Colitis ulcerative, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, MESALAMINE, |
||||
| 109 | 26536959 |
US |
70 | 2 |
Influenza, Neuropathy peripheral, Herpes zoster, Parosmia, |
||||
LENALIDOMIDE, |
||||
| 110 | 26537042 |
CA |
2 | |
Cardiac septal defect, Pericardial effusion, Hypotension, Influenza, Fall, Contusion, Product dose omission issue, |
||||
IXAZOMIB, |
||||
| 111 | 26537060 |
US |
68 | 2 |
Pneumonia, Urinary tract infection, Influenza, Bronchitis, Asthenia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 112 | 26537087 |
US |
74 | 2 |
Influenza, COVID-19, |
||||
DUPILUMAB, |
||||
| 113 | 26537171 |
EU |
7 | 1 |
Oxygen saturation decreased, Dyspnoea, Product dose omission issue, Influenza, Productive cough, Pyrexia, |
||||
IDURSULFASE, IDURSULFASE, IDURSULFASE, IDURSULFASE, |
||||
| 114 | 26537941 |
BR |
53 | 2 |
Breast abscess, Influenza, |
||||
GOLIMUMAB, GOLIMUMAB, PENICILLIN G BENZATHINE, VITAMIN C, |
||||
| 115 | 26538108 |
US |
64 | 1 |
Influenza, |
||||
DUPILUMAB, |
||||
| 116 | 26538466 |
53 | ||
Hospitalisation, Haemoptysis, Influenza, Illness, |
||||
ZILUCOPLAN, ZILUCOPLAN, ZILUCOPLAN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PANTOPRAZOLE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PREDNISONE, PYRIDOSTIGMINE BROMIDE ORAL, TOPIRAMATE, TOPIRAMATE SPINKLE, ERGOCALCIFEROL, VITAMIN C, BUPROPION, DICLOFENAC, DICLOFENAC SODIUM, GABAPENTIN, HYDROXYZINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PYRIDOSTIGMINE BROMIDE, |
||||
| 117 | 26538470 |
CA |
25 | |
COVID-19, Illness, Food poisoning, Malaise, Influenza, Overdose, Product dose omission issue, Off label use, Intentional dose omission, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 118 | 26539212 |
US |
49 | 2 |
Pulmonary embolism, Product administration interrupted, Insurance issue, Product dose omission issue, Influenza, Haemoglobin decreased, |
||||
MITAPIVAT, |
||||
| 119 | 26539278 |
CA |
2 | |
Anxiety, Influenza, Cholelithiasis, Panic reaction, Psoriasis, Feeling abnormal, Dry skin, Scab, |
||||
RISANKIZUMAB-RZAA, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 120 | 26539381 |
US |
||
Influenza, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 121 | 26539560 |
US |
1 | |
Influenza, |
||||
DUPILUMAB, |
||||
| 122 | 26539920 |
US |
74 | 2 |
Influenza, Aphonia, |
||||
INSULIN GLARGINE AND LIXISENATIDE, |
||||
| 123 | 26540181 |
US |
4 | 1 |
Hand-foot-and-mouth disease, Influenza, Respiratory syncytial virus infection, Infusion site bruising, Pyrexia, Ear tube insertion, Adenoidectomy, |
||||
LARONIDASE, |
||||
| 124 | 26540260 |
US |
69 | 1 |
Influenza, |
||||
ACOLTREMON, |
||||
| 125 | 26540309 |
US |
82 | 2 |
Eye pain, Influenza, Condition aggravated, |
||||
ACOLTREMON, ERYTHROMYCIN, CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN, |
||||
| 126 | 26540620 |
CA |
66 | 1 |
Pneumonia, Cardiac fibrillation, Influenza, |
||||
RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, |
||||
| 127 | 26540813 |
US |
9 | 1 |
Influenza, Pyrexia, Oropharyngeal pain, Cough, Influenza, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 128 | 26540924 |
US |
83 | 2 |
Influenza, Dysphonia, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 129 | 26540966 |
US |
16 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 130 | 26541312 |
|||
Influenza, COVID-19, Insurance issue, Illness, Rash, Pain, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ERGOCALCIFEROL, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, ERGOCALCIFEROL, UPADACITINIB, |
||||
| 131 | 26541747 |
CA |
3 | 2 |
Pneumonia, Illness, Endometriosis, Migraine, Decreased appetite, Vomiting, Dizziness, Hormone level abnormal, Influenza, |
||||
INFLIXIMAB, |
||||
| 132 | 26531123 |
EU |
36 | 2 |
Influenza, Viral infection, Gastrointestinal infection, Herpes virus infection, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 133 | 26531367 |
US |
1 | |
Influenza, Bronchitis, |
||||
RAVULIZUMAB, |
||||
| 134 | 26531624 |
US |
||
Anaemia, Cystitis, Illness, Bronchitis, Influenza, Vomiting, Diarrhoea, Viral infection, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 135 | 26532091 |
US |
72 | 2 |
Influenza, |
||||
IXEKIZUMAB, TIRZEPATIDE, |
||||
| 136 | 26532155 |
GB |
2 | |
Pneumonia, Organ failure, Influenza, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 137 | 26532447 |
CA |
1 | |
Influenza, |
||||
BENRALIZUMAB, BENRALIZUMAB, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 138 | 26532758 |
GB |
2 | |
Lower respiratory tract infection, Influenza, |
||||
SECUKINUMAB, |
||||
| 139 | 26532943 |
US |
1 | |
Pain of skin, Skin disorder, Cardiac disorder, Sinusitis, Allergy to metals, Influenza, |
||||
CLONIDINE HYDROCHLORIDE, VITAMIN C, ERGOCALCIFEROL, MORPHINE SULFATE, ICATIBANT ACETATE, HYDROCHLOROTHIAZIDE, DANAZOL, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, SPIRONOLACTONE, |
||||
| 140 | 26532982 |
US |
2 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 141 | 26533093 |
US |
1 | 1 |
Influenza, Pyrexia, Dermatitis diaper, |
||||
DUPILUMAB, |
||||
| 142 | 26533133 |
US |
43 | |
Influenza, Intercepted product dispensing error, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 143 | 26533391 |
US |
71 | 2 |
Influenza, Nasal congestion, Bronchitis, Dyspnoea, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 144 | 26533394 |
US |
1 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 145 | 26533500 |
US |
59 | 2 |
Chronic obstructive pulmonary disease, Nasopharyngitis, Influenza, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 146 | 26533611 |
US |
62 | 1 |
Sleep disorder due to a general medical condition, Influenza, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 147 | 26534152 |
US |
||
Influenza, |
||||
INTERFERON BETA-1A, |
||||
| 148 | 26534231 |
GB |
77 | 1 |
Abscess, Back pain, Hypophagia, Respiratory syncytial virus infection, Influenza, Pneumonia, Mass, |
||||
POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, BISOPROLOL FUMARATE, RAMIPRIL, |
||||
| 149 | 26534242 |
US |
45 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 150 | 26534264 |
US |
69 | 2 |
Influenza, Overweight, Product use issue, |
||||
VORTIOXETINE, |
||||
| 151 | 26534421 |
US |
||
Influenza, Pain, Headache, Fatigue, |
||||
ETRANACOGENE DEZAPARVOVEC, |
||||
| 152 | 26534738 |
US |
76 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 153 | 26534820 |
US |
1 | |
Influenza, Norovirus infection, Pyrexia, Vomiting, Hand-foot-and-mouth disease, Conjunctivitis, |
||||
DUPILUMAB, |
||||
| 154 | 26534830 |
US |
49 | 1 |
Influenza, |
||||
AGALSIDASE BETA, |
||||
| 155 | 26534857 |
US |
68 | 1 |
Influenza, |
||||
DUPILUMAB, |
||||
| 156 | 26534892 |
US |
26 | |
Influenza, Hypernatraemia, |
||||
VIGABATRIN, VIGABATRIN, |
||||
| 157 | 26534899 |
US |
46 | 1 |
Influenza, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TESTOSTERONE CYPIONATE, CYANOCOBALAMIN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
| 158 | 26535194 |
US |
59 | 2 |
Hypertension, COVID-19, Impaired gastric emptying, Metabolic disorder, Postprandial hypoglycaemia, Illness, Body temperature decreased, Vomiting, Alopecia, Dehydration, Headache, Blood glucose increased, Autoimmune disorder, Antinuclear antibody positive, Psoriasis, Sinusitis, Influenza, Dumping syndrome, Inappropriate schedule of product administration, Therapeutic response decreased, Overdose, Drug ineffective, Product use issue, |
||||
IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, TIRZEPATIDE, DULAGLUTIDE, LIRAGLUTIDE, |
||||
| 159 | 26535670 |
US |
71 | 1 |
Influenza, Pneumonia, Dyspnoea, |
||||
IXAZOMIB, ACYCLOVIR, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DULOXETINE HYDROCHLORIDE, GABAPENTIN, GLIPIZIDE, GLIPIZIDE-TABLETS, MAGNESIUM OXIDE, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, POMALIDOMIDE, ICOSAPENT ETHYL, DENOSUMAB, |
||||
| 160 | 26538435 |
45 | 2 | |
Hypersensitivity, Influenza, Contraindicated product prescribed, Contraindicated product administered, Drug hypersensitivity, Burning sensation, Blood pressure increased, Fatigue, Dyspnoea, Gait inability, Immunodeficiency, Aphasia, Feeding disorder, Mast cell activation syndrome, Premature menopause, Alopecia, Muscle atrophy, Amnesia, Chronic fatigue syndrome, Fibromyalgia, Guillain-Barre syndrome, |
||||
PREDNISONE, ERGOCALCIFEROL, |
||||
| 161 | 26526837 |
US |
2 | |
Influenza, |
||||
TROFINETIDE, TROFINETIDE, |
||||
| 162 | 26527111 |
US |
23 | 2 |
Influenza, |
||||
EVEROLIMUS, |
||||
| 163 | 26527359 |
US |
24 | 1 |
Influenza, Device defective, |
||||
TRALOKINUMAB-LDRM, |
||||
| 164 | 26527402 |
US |
73 | 2 |
White blood cell count increased, Influenza, |
||||
LENALIDOMIDE, |
||||
| 165 | 26527458 |
US |
||
Influenza, |
||||
MIRIKIZUMAB-MRKZ, |
||||
| 166 | 26527664 |
US |
2 | 2 |
Influenza, |
||||
| 167 | 26528042 |
CA |
63 | 2 |
Pneumonia, Influenza, |
||||
BENRALIZUMAB, BENRALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE INHALATION SPRAY, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
| 168 | 26528277 |
US |
60 | 1 |
Influenza, Rhinovirus infection, |
||||
TREPROSTINIL, TREPROSTINIL, TIOTROPIUM BROMIDE INHALATION SPRAY, GLUCAGON, ROSUVASTATIN CALCIUM, SERTRALINE HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, BUMETANIDE, MAGNESIUM OXIDE, ALBUTEROL SULFATE, MESALAMINE, METOLAZONE, SILDENAFIL CITRATE, SILDENAFIL, ALPRAZOLAM, EPLERENONE, INSULIN LISPRO, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYGEN, 0XYGEN, FOLIC ACID, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MEPOLIZUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, IRON, |
||||
| 169 | 26528308 |
US |
50 | 2 |
Sepsis, Malnutrition, Nephrolithiasis, Blood immunoglobulin G decreased, Urinary tract infection, Cystitis, Upper respiratory tract infection, Hypotension, Hypersensitivity, Influenza, Fatigue, |
||||
ACALABRUTINIB, |
||||
| 170 | 26528731 |
CN |
70 | 2 |
Acute respiratory failure, Pneumonia, Myelosuppression, Aspergillus infection, Influenza, Leukopenia, Thrombocytopenia, Product use in unapproved indication, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, POLATUZUMAB VEDOTIN, BENDAMUSTINE HCL, |
||||
| 171 | 26529068 |
EU |
77 | 2 |
Scleroderma, Influenza, Headache, Nausea, Decreased appetite, Initial insomnia, Mouth haemorrhage, Skin ulcer, Myalgia, Hot flush, Diarrhoea, Gastrooesophageal reflux disease, Nasal congestion, Rash erythematous, Blood pressure systolic abnormal, Abdominal pain, Tachycardia, Palpitations, Constipation, Hypotension, |
||||
IRON, IRON, IRON, IRON, BOSENTAN, BOSENTAN, BOSENTAN, BOSENTAN, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR PHOSPHATE, TADALAFIL, TADALAFIL, TADALAFIL, TADALAFIL, |
||||
| 172 | 26529226 |
|||
Malaise, Pyrexia, Influenza, |
||||
RESMETIROM, |
||||
| 173 | 26529303 |
70 | ||
Influenza, Stomatitis, Back pain, Bronchitis, Cough, Nasal congestion, Gout, Constipation, Abdominal pain upper, Pruritus, Dizziness, Diarrhoea, Nausea, Abdominal pain, |
||||
RESMETIROM, FLUTICASONE PROPIONATE AND SALMETEROL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 174 | 26529646 |
US |
1 | |
Lower respiratory tract infection, Influenza, Ear infection, Gastroenteritis viral, |
||||
HUMAN IMMUNOGLOBULIN G, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, ERGOCALCIFEROL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ALBUTEROL SULFATE, |
||||
| 175 | 26529990 |
MX |
13 | 1 |
Influenza, Oxygen saturation decreased, |
||||
ELOSULFASE ALFA, |
||||
| 176 | 26530034 |
BR |
49 | 2 |
Pneumonia, Influenza, Inappropriate schedule of product administration, |
||||
INFLIXIMAB, |
||||
| 177 | 26530078 |
US |
26 | 2 |
Influenza, Off label use, |
||||
TOBRAMYCIN, RISANKIZUMAB-RZAA, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, AZTREONAM, |
||||
| 178 | 26530103 |
2 | ||
Influenza, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 179 | 26530442 |
TW |
||
Neutropenia, Sepsis, Thrombocytopenia, Cytokine release syndrome, Pneumonia, Pneumocystis jirovecii infection, Neuropathy peripheral, Hepatotoxicity, Hypogammaglobulinaemia, Immune effector cell-associated neurotoxicity syndrome, Febrile neutropenia, Anaemia, Cytomegalovirus infection, Herpes zoster, Influenza, COVID-19, Headache, Fatigue, |
||||
| 180 | 26533465 |
2 | ||
Influenza, |
||||
CYCLOBENZAPRINE, LORAZEPAM, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, IBUPROFEN, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 181 | 26522579 |
CN |
11 | 1 |
Purtscher retinopathy, Retinal haemorrhage, Blindness, Cystoid macular oedema, Metamorphopsia, Retinal exudates, Retinal deposits, Macular oedema, Retinal ischaemia, Optic disc oedema, Visual acuity reduced, Papilloedema, Thrombotic microangiopathy, Thrombocytopenia, Proteinuria, Renal impairment, Effusion, Vitreous opacities, H1N1 influenza, Influenza, Adenovirus infection, Human herpesvirus 6 infection, Endothelial dysfunction, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, INOTUZUMAB OZOGAMICIN, INOTUZUMAB OZOGAMICIN, INOTUZUMAB OZOGAMICIN, INOTUZUMAB OZOGAMICIN, BELIMUMAB, BELIMUMAB, BELIMUMAB, BELIMUMAB, ETOPOSIDE, CLADRIBINE, CYTARABINE, CYCLOSPORINE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, |
||||
| 182 | 26522666 |
GB |
||
Cellulitis, Influenza, Myocardial infarction, Respiratory syncytial virus infection, Renal cell carcinoma, Infection, Cerebrovascular accident, Pneumonia, Herpes ophthalmic, Rheumatoid arthritis, Nasopharyngitis, Drug specific antibody, Rash pruritic, Lipids increased, Upper respiratory tract infection, Bronchitis, Headache, Infusion related reaction, Hypersensitivity, Off label use, |
||||
NIPOCALIMAB, |
||||
| 183 | 26522693 |
US |
2 | |
Influenza, |
||||
PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, |
||||
| 184 | 26522784 |
65 | ||
Knee arthroplasty, Dizziness, Peripheral swelling, Joint swelling, Oral disorder, Influenza, Intentional dose omission, Walking aid user, Inappropriate schedule of product administration, Product dose omission issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CHLORTHALIDONE, SULFASALAZINE, HYDROXYCHLOROQUINE, |
||||
| 185 | 26522875 |
54 | ||
Influenza, |
||||
BIMEKIZUMAB, |
||||
| 186 | 26522892 |
CA |
32 | |
Abdominal pain, Anxiety, Asthma, Bacterial infection, Blood pressure increased, Decreased activity, Dyspnoea, Dyspnoea exertional, Ear infection, Eczema, Emphysema, Eosinophil count abnormal, Feeding disorder, Forced expiratory volume decreased, Full blood count abnormal, Fungal infection, Heart rate increased, Infection, Influenza, Malaise, Middle insomnia, Migraine, Musculoskeletal chest pain, Nasal congestion, Nasal discharge discolouration, Nasopharyngitis, Obstructive airways disorder, Oropharyngeal pain, Pain, Pneumonia, Productive cough, Psoriasis, Rales, Restrictive pulmonary disease, Rhinitis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Stress, Tachycardia, Terminal insomnia, Tooth abscess, Upper-airway cough syndrome, Urinary tract infection, Vertigo, Vomiting, Wheezing, Cough, Dizziness, Diarrhoea, Urticaria, Drug ineffective, Product administration error, Therapeutic response decreased, Therapeutic product effect decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, MONTELUKAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TERBUTALINE SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, EPINEPHRINE, CICLESONIDE, QUETIAPINE FUMARATE, QUETIAPINE, SEMAGLUTIDE, SEMAGLUTIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 187 | 26523040 |
US |
64 | 2 |
Influenza, |
||||
POMALIDOMIDE, |
||||
| 188 | 26523279 |
EU |
1 | |
Influenza, Musculoskeletal stiffness, |
||||
| 189 | 26523455 |
CN |
70 | 2 |
Acute respiratory failure, Pneumonia, Aspergillus infection, Influenza, Myelosuppression, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, PREDNISONE, |
||||
| 190 | 26523488 |
75 | ||
Chronic kidney disease, Influenza, Nasopharyngitis, Hot flush, |
||||
BIMEKIZUMAB, |
||||
| 191 | 26523627 |
US |
||
Off label use, COVID-19, Urinary tract infection, Cystitis, Bronchitis, Pneumonia, Herpes zoster, Influenza, Ear infection, |
||||
RITUXIMAB, |
||||
| 192 | 26523664 |
US |
76 | 2 |
Influenza, |
||||
DUPILUMAB, |
||||
| 193 | 26523923 |
US |
56 | 1 |
Influenza, |
||||
POMALIDOMIDE, |
||||
| 194 | 26524377 |
US |
46 | 2 |
Influenza, |
||||
| 195 | 26524679 |
US |
53 | 2 |
Pneumonia, Influenza, Sleep deficit, Asthenia, |
||||
AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, ALBUTEROL SULFATE, ALBUTEROL, ARMODAFINIL, NEBIVOLOL HYDROCHLORIDE, CLONIDINE, CLONIDINE, CYCLOBENZAPRINE, ADALIMUMAB, HYDROXYCHLOROQUINE, OXYCODONE, OXYGEN, 0XYGEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, CYCLOSPORINE, CETIRIZINE HYDROCHLORIDE, |
||||
| 196 | 26524990 |
US |
2 | |
Influenza, |
||||
OSIMERTINIB, MOMETASONE, PANTOPRAZOLE, OSELTAMIVIR PHOSPHATE, CALCIUM, PREDNISONE, ERGOCALCIFEROL, LATANOPROST, HYDROCHLOROTHIAZIDE, |
||||
| 197 | 26525069 |
US |
2 | |
Off label use, Blood magnesium decreased, Asthma, Influenza like illness, Confusional state, Urinary tract infection, Blood potassium decreased, Decreased appetite, Diarrhoea, Vomiting, Asthenia, Vaginal haemorrhage, Sinusitis, Influenza, Anxiety, Headache, Abdominal pain upper, Fatigue, |
||||
OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, MIFEPRISTONE, |
||||
| 198 | 26525251 |
US |
84 | 2 |
Pneumonia, Influenza, Memory impairment, Incorrect dose administered, Wrong technique in product usage process, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 199 | 26526043 |
89 | 2 | |
Fall, Fatigue, Coronary artery stenosis, Influenza, Ulcer haemorrhage, Anal incontinence, Constipation, Swelling, Fatigue, Hypertension, Arthritis, Diarrhoea, Product dose omission issue, Intentional dose omission, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, NIFEDIPINE, ROSUVASTATIN, |
||||
| 200 | 26526502 |
US |
2 | |
Influenza, Hepatic enzyme increased, Iron overload, Treatment noncompliance, Off label use, |
||||
MITAPIVAT, MITAPIVAT, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, ASCORBIC ACID, DEFERASIROX, FOLIC ACID, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, POLYETHYLENE GLYCOL 3350, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
